MEDIPOST Co., Ltd. (KOSDAQ:078160)
8,790.00
-160.00 (-1.79%)
Sep 1, 2026, 3:30 PM KST
MEDIPOST Market Cap
MEDIPOST has a market cap or net worth of 349.82 billion as of September 1, 2026. Its market cap has decreased by -3.03% in one year.
Market Cap
349.82B
Enterprise Value
317.03B
Revenue
74.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,790.00
ChartMarket Cap Chart
Since July 29, 2005, MEDIPOST's market cap has increased from 189.41B to 349.82B, an increase of 84.69%. That is a compound annual growth rate of 2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 343.56B | -51.68% |
| Dec 30, 2025 | 710.97B | 80.99% |
| Dec 30, 2024 | 392.82B | 41.18% |
| Dec 28, 2023 | 278.25B | 15.66% |
| Dec 29, 2022 | 240.56B | -30.37% |
| Dec 30, 2021 | 345.51B | -35.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GI Innovation | 527.74B |
| AbClon | 490.82B |
| GC Corp. | 455.38B |
| Medy-Tox | 449.06B |
| Proteina | 396.16B |
| SillaJen | 356.78B |
| Genomictree | 276.90B |
| NeoImmuneTech | 248.16B |